Table 2.
Characteristics (n = 116) | WT (n) | TERTp (n) |
---|---|---|
Age (in years) | ||
≤51 | 39 | 4 |
>51 | 66 | 7 |
Gender | ||
Male | 57 | 7 |
Female | 48 | 4 |
Race | ||
Caucasian | 99 | 11 |
Non Caucasian | 6 | 0 |
Tumor location | ||
Abdominal | 16 | 0 |
Arm/forearm | 7 | 0 |
Cervical | 5 | 0 |
Femoral | 11 | 3 |
Head | 3 | 0 |
Hip | 5 | 1 |
Jaw | 2 | 1 |
Knee | 1 | 1 |
Leg | 4 | 0 |
Lung | 8 | 1 |
Retroperitoneal | 18 | 0 |
Spine | 2 | 1 |
Testis | 4 | 0 |
Thigh | 4 | 1 |
Others | 15 | 2 |
Grade | ||
G1/well differentiated | 16 | 5 |
G2-G3 | 86 | 6 |
NA | 3 | 0 |
Disease progression | ||
No | 53 | 5 |
Yes | 45 | 3 |
NA | 7 | 3 |
Metastasis | ||
Absent | 55 | 6 |
Present | 42 | 2 |
NA | 8 | 3 |
N—number of cases. Tumor location “Others” included bladder, ear, gluteus, groin, liver, maxilla, nose, paravertebral, parotis, pleural, prostate, renal, rip/sternum, shoulder, skin, Vena cava. NA—not available. Disease progression during follow-up. Metastasis during follow-up.